Surgery Partners (NASDAQ:SGRY) Now Covered by KeyCorp

KeyCorp assumed coverage on shares of Surgery Partners (NASDAQ:SGRYFree Report) in a report published on Friday, Marketbeat Ratings reports. The brokerage issued a sector weight rating on the stock. KeyCorp also issued estimates for Surgery Partners’ FY2024 earnings at $0.81 EPS.

SGRY has been the topic of a number of other research reports. Royal Bank of Canada reissued an outperform rating and issued a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. StockNews.com lowered Surgery Partners from a hold rating to a sell rating in a research note on Wednesday, August 7th. Benchmark reissued a buy rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. Macquarie initiated coverage on Surgery Partners in a research note on Friday, June 28th. They issued an outperform rating and a $31.00 price objective on the stock. Finally, Citigroup reduced their price objective on Surgery Partners from $38.00 to $36.00 and set a buy rating on the stock in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Surgery Partners presently has an average rating of Moderate Buy and an average price target of $39.63.

View Our Latest Report on SGRY

Surgery Partners Price Performance

Shares of SGRY stock opened at $31.75 on Friday. The stock’s fifty day simple moving average is $30.79 and its 200 day simple moving average is $27.81. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69. The firm has a market cap of $4.04 billion, a price-to-earnings ratio of -117.59, a P/E/G ratio of 2.33 and a beta of 2.75. Surgery Partners has a one year low of $22.05 and a one year high of $36.92.

Surgery Partners (NASDAQ:SGRYGet Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. The business had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. Surgery Partners’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.25 EPS. On average, analysts expect that Surgery Partners will post 0.86 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Surgery Partners

A number of institutional investors and hedge funds have recently made changes to their positions in the company. DekaBank Deutsche Girozentrale increased its holdings in Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after purchasing an additional 1,375 shares during the last quarter. Quarry LP increased its holdings in Surgery Partners by 133.1% in the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares during the last quarter. EntryPoint Capital LLC increased its holdings in Surgery Partners by 257.1% in the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after purchasing an additional 4,607 shares during the last quarter. Creative Planning bought a new stake in Surgery Partners in the third quarter valued at about $258,000. Finally, Capstone Investment Advisors LLC increased its holdings in Surgery Partners by 38.7% in the first quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock valued at $273,000 after purchasing an additional 2,551 shares during the last quarter.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Further Reading

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.